المؤلفون: Parsons, C. M., Harvey, N., Shepstone, L., Kanis, J. A., Lenaghan, E., Clarke, S., Fordham, R., Gittoes, N., Harvey, I., Holland, R., Redmond, N. M., Howe, A., Marshall, T., Peters, T. J., Torgerson, D., O’Neill, T. W., McCloskey, E., Cooper, C., Crabtree, N., Duffy, H., Parle, J., Rashid, F., Stant, K., Taylor, K., Thomas, C., Knox, E., Tenneson, C., Williams, H., Adams, D., Bion, V., Blacklock, J., Dyer, T., Bratherton, S., Fidler, M., Knight, K., McGurk, C., Smith, K., Young, S., Collins, K., Cushnaghan, J., Arundel, C., Bell, K., Clark, L., Collins, S., Gardner, S., Mitchell, N., the Scoop Trial Group

مصطلحات موضوعية: adherence, epidemiology, FRAX®, medication, osteoporosis, screening

العلاقة: https://acuresearchbank.acu.edu.au/item/8vzv0/systematic-screening-using-frax-leads-to-increased-use-of-and-adherence-to-anti-osteoporosis-medications-an-analysis-of-the-ukTest-scoop-trial; https://doi.org/10.1007/s00198-019-05142-zTest; Parsons, C. M., Harvey, N., Shepstone, L., Kanis, J. A., Lenaghan, E., Clarke, S., Fordham, R., Gittoes, N., Harvey, I., Holland, R., Redmond, N. M., Howe, A., Marshall, T., Peters, T. J., Torgerson, D., O’Neill, T. W., McCloskey, E., Cooper, C., Crabtree, N., . the Scoop Trial Group. (2020). Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial. Osteoporosis International. 31(1), pp. 67-75. https://doi.org/10.1007/s00198-019-05142-zTest

الإتاحة: https://doi.org/10.1007/s00198-019-05142-zTest

المؤلفون: Parsons, C. M., Harvey, N., Shepstone, L., Kanis, J. A., Lenaghan, E., Clarke, S., Fordham, R., Gittoes, N., Harvey, I., Holland, R., Redmond, N. M., Howe, A., Marshall, T., Peters, T. J., Torgerson, D., O’Neill, T. W., McCloskey, E., Cooper, C., Crabtree, N., Duffy, H., Parle, J., Rashid, F., Stant, K., Taylor, K., Thomas, C., Knox, E., Tenneson, C., Williams, H., Adams, D., Bion, V., Blacklock, J., Dyer, T., Bratherton, S., Fidler, M., Knight, K., McGurk, C., Smith, K., Young, S., Collins, K., Cushnaghan, J., Arundel, C., Bell, K., Clark, L., Collins, S., Gardner, S., Mitchell, N., the Scoop Trial Group

المصدر: Parsons, C, Harvey, N C, Shepstone, L, Kanis, J A, Lenaghan, E, Fordham, R, Gittoes, N, Harvey, I, Holland, R, Redmond, N M, Howe, A, Marshall, T, Peters, TJ, Torgerson, D, O'Neill, T W, McCloskey, E & Cooper, C 2019, ' Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications : An analysis of the UK SCOOP Trial ', Osteoporosis International . https://doi.org/10.1007/s00198-019-05142-zTest

مصطلحات موضوعية: medicine.medical_specialty, Hip fracture, FRAX, business.industry, Cost effectiveness, screening, Endocrinology, Diabetes and Metabolism, Osteoporosis, FRAX®, medicine.disease, Logistic regression, osteoporosis, Rheumatology, Internal medicine, Epidemiology, Orthopedic surgery, medicine, epidemiology, medication, adherence, business

وصف الملف: text; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b69e0a13c3ca93cc63da4e22dc0732Test
https://eprints.soton.ac.uk/433607Test/